Vascular Behçet syndrome: from pathogenesis to treatment

A Bettiol, F Alibaz-Oner, H Direskeneli… - Nature Reviews …, 2023 - nature.com
Behçet syndrome is a rare, chronic inflammatory disease of unknown aetiopathogenesis,
most commonly presenting with mucocutaneous and ocular manifestations. Vascular …

[PDF][PDF] Behçet's syndrome: One year in review 2023

G Hatemi, E Seyahi, I Fresko, R Talarico… - Clin. Exp …, 2023 - clinexprheumatol.org
This critical review of studies on Behçet's syndrome published during 2022 includes studies
on epidemiology, patients' perspective, pathogenesis, diagnosis, clinical features and …

Anticoagulant Treatment May Decrease the Relapse Rate of Pulmonary Arterial Involvement in Behçet's Disease

KY Abacar, AE Boncukcuoglu, A Aksoy… - JCR: Journal of …, 2024 - journals.lww.com
Objectives Pulmonary arterial involvement (PAI) is one of the most common causes of
mortality in Behçet's disease (BD). In this study, we aimed to evaluate the clinical features …

Evaluation of inflammatory-thrombosis panel as a diagnostic tool for vascular Behçet's disease

H Zhan, L Cheng, H Chen, Y Liu, X Feng, H Li, Z Li… - Clinical …, 2025 - Springer
Abstract Objectives Vascular Behçet's disease (VBD) is prevalent in 40% of BD, but lacks
laboratory biomarker for timely diagnosis. We aimed to establish a diagnostic panel for …

Case report and analysis: Behçet's disease with lower extremity vein thrombosis and pseudoaneurysm

HL Wang, JH Zhang, YC Wu, JL Lin, Y Tang… - Frontiers in …, 2022 - frontiersin.org
Background Behçet's disease (BD) is a unique autoimmune chronic systemic vasculitis that
affects veins and arteries of all sizes. BD can lead to recurrent vascular events, especially …

Current pharmacological solutions for Behcet's syndrome

Y Ozguler, SN Esatoglu, G Hatemi - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Behçet's syndrome (BS) has a heterogeneous clinical phenotype, and its
clinical manifestations may respond differently to drugs commonly used to treat BS. The …

Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?

A Aksoy, D Kocakaya, O Demircioglu, NC Cimsit… - Respiratory …, 2024 - Elsevier
Introduction Behcet's disease (BD) is a chronic inflammatory disorder with arterial vasculitis.
Although, pulmonary artery aneurysm (PAA) is accepted as the prototypic arterial disorder …

Does anticoagulation in combination with immunosuppressive therapy prevent recurrent thrombosis in Behçet's disease?

S Erol, A Gürün Kaya, F Arslan… - Journal of …, 2024 - journals.sagepub.com
Vascular involvement in Behçet's disease (BD) occurs in up to 50% of patients. The main
mechanism of thrombosis is inflammation. Thus, immunosuppressants (IS) are the mainstay …

Investigation of possible predictive factors, clinical characteristics, and treatment in vascular Behçet's disease: real-life data from a single center

A Kahveci, ZK Cevval - Hitit Medical Journal, 2024 - dergipark.org.tr
Objective: The aim of this study was to investigate the phenotypes, predictive factors, and
treatment approach of Behçet's patients with vascular involvement. Material and Method …

[PDF][PDF] Surgery Research Journal

BI DIARRA - 2023 - sciencexcel.com
Introduction: Behçet's disease is a chronic inflammatory disorder. It is clinically characterized
by oral and genital aphthoses; skin lesions and systemic manifestations. Arterial aneurysms …